Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein

Archives of Virology

Volumn 155, Issue 11, 2010, Pages 1765-1775

  Guo, Lina ^a   Zheng, Mei ^a   Ding, Yahong ^a   Li, Dongmei ^a   Yang, Zhongdong ^a   Wang, Haiming ^a   Chen, Quanjiao ^b   Sui, Zhiwei ^b   Fang, Fang ^c   Chen, Ze ^a,b,c  

^a SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c HUNAN NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; NUCLEOPROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CLASSIFICATION; FEMALE; GERMFREE ANIMAL; IMMUNOLOGY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; INTRANASAL DRUG ADMINISTRATION; MOUSE; ORTHOMYXOVIRUS INFECTION; PASSIVE IMMUNIZATION; VIROLOGY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; CHOLERA TOXIN; FEMALE; IMMUNIZATION, PASSIVE; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZAVIRUS A; MUS; ORTHOMYXOVIRIDAE; PROKARYOTA;

EID: 78149410526     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0756-3     Document Type: Article

References (45)

1. Horimoto T, Kawaoka Y (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3: 591-600.
2. Kaiser J (2006) A one-size-fits-all flu vaccine? Science 312: 380-382.
3. Luo M, Tao P, Li J et al (2008) Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. J Virol Methods 154: 121-127.
4. Epstein SL, Tumpey TM, Misplon JA et al (2002) DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis 8: 796-801.
5. Ulmer JB, Donnelly JJ, Parker SE et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745-1749.
6. Altstein AD, Gitelman AK, Smirnov YA et al (2006) Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol 151: 921-931.
7. Epstein SL, Kong WP, Misplon JA et al (2005) Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23: 5404-5410.
8. Roy S, Kobinger GP, Lin J et al (2007) Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 25: 6845-6851.
9. Thomas PG, Keating R, Hulse-Post DJ et al (2006) Cell-mediated protection in influenza infection. Emerg Infect Dis 12: 48-54.
10. Adar Y, Singer Y, Levi P et al (2009) A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 27: 2099-2107.
11. Zhirnov OP, Isaeva EI, Konakova TE et al (2007) Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1. Influenza Other Respi Viruses 1: 71-79.
12. Tumpey TM, Renshaw M, Clements JD et al (2001) Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-Protection against lethal influenza A H5N1 virus infection. J Virol 75: 5141-5150.
13. Takada A, Matsushita S, Ninomiya A et al (2003) Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 21: 3212-3218.
14. Bright RA, Carter DM, Crevar CJ et al (2008) Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 3: 1501-1512.
15. Freytag LC, Clements JD (2005) Mucosal adjuvants. Vaccine 23: 1804-1813.
16. Tamura S-I, Yamanaka A, Shimohara M et al (1994) Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 12: 419-426.
17. Qiu M, Fang F, Chen Y et al (2006) Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Biochem Biophys Res Commun 343: 1124-1131.
18. Zheng L, Wang F, Yang Z et al (2009) A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice. BMC Infect Dis 9: 17.
19. Tamura S-I, Miyata K, Matwo K et al (1996) Acceleration of influenza virus clearance by Thl cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J Immunol 156: 3892-3900.
20. Chen Z, Sahashi Y, Matsuo K et al (1998) Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 16: 1544-1549.
21. Zhu Q, Chang H, Chen Y et al (2005) Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice. Biochem Biophys Res Commun 329: 87-94.
22. Chen Q, Kuang H, Wang H et al (2009) Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus. Virus Genes 38: 30-38.
23. Deng YJ, Yewdell W, Eisenlohr LC et al (1997) MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol 158: 1507-1515.
24. Gao XM, Liew FY, Tite JP (1989) Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus. J Immunol 143: 3007-3014.
25. Chen J, Zhang F, Fang F et al (2007) Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody. BMC Infect Dis 7: 118.
26. Zhang F, Chen J, Fang F et al (2005) Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice. DNA Cell Biol 24: 758-765.
27. Powell TJ, Strutt T, Reome J et al (2007) Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus. J Immunol 178: 1030-1038.
28. Andrew ME, Coupar BE, Boyle DB et al (1987) The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand J Immunol 25: 21-28.
29. Webster RG, Kawaoka Y, Taylor J et al (1991) Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9: 303-308.
30. Barefoot BE, Sample CJ, Ramsburg EA (2009) Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus. Clin Vaccine Immunol 16: 488-498.
31. Wesley RD, Tang M, Lager KM (2004) Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 22: 3427-3434.
32. Macklin MD, McCabe D, McGregor MW et al (1998) Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J Virol 72: 1491-1496.
33. Tite JP, Hughes-Jenkins C, O'Callaghan D et al (1990) Antiviral immunity induced by recombinant nucleoprotein of influenza A virus II Protection from influenza infection and mechanism of protection. Immunology 71: 202-207.
34. Mazanec MB, Kaetzel CS, Lamm ME et al (1992) Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci 89: 6901-6905.
35. Mazanec MB, Coudret CL, Fletcher DR (1995) Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 69: 1339-1343.
36. Yan H, Lamm ME, Bjorling E et al (2002) Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model. J Virol 76: 10972-10979.
37. Huang YT, Wright A, Gao X et al (2005) Intraepithelial cell neutralization of HIV-1 replication by IgA. J Immunol 174: 4828-4835.
38. Corthesy B, Benureau Y, Perrier C et al (2006) Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol 80: 10692-10699.
39. Wright A, Yan H, Lamm ME et al (2006) Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells. Virology 356: 165-170.
40. Epstein SL, Lo CY, Misplon JA et al (1998) Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol 160: 322-327.
41. 2-microglobulin-deficient, and J chain-deficient mice. J Immunol 158: 1222-1230.
42. Zheng B, Zhang Y, He H et al (2007) Rectification of age-associated deficiency in cytotoxic T cell response to influenza a virus by immunization with immune complexes. J Immunol 179: 6153-6159.
43. Carragher DM, Kaminski DA, Moquin A et al (2008) A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J Immunol 181: 4168-4176.
44. Haller O, Staeheli P, Kochs G (2007) Interferon-induced Mx proteins in antiviral host defense. Biochimie 89: 812-818.
45. Tumpey TM, Szretter KJ, van Hoeven N et al (2007) The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 81: 10818-10821.